RecruitingNCT06560606
UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Studying Juvenile idiopathic arthritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Hospital for Sick Children
- Principal Investigator
- Rae SM Yeung, MD, PhD, FRCPCThe Hospital for Sick Children (SickKids), University of Toronto
- Enrollment
- 4100 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2027
Study locations (19)
- Alberta Children's Hospital - University of Calgary, Calgary, Alberta, Canada
- Stollery Children's Hospital, Edmonton, Alberta, Canada
- BC Children's Hospital, Vancouver, British Columbia, Canada
- Children's Hospital Health Science Centre Winnipeg, Winnipeg, Manitoba, Canada
- Janeway Children's Hospital and Rehabilitation Centre, St. John's, Newfoundland and Labrador, Canada
- IWK Health Centre, Halifax, Nova Scotia, Canada
- McMaster Children's Hospital, Hamilton, Ontario, Canada
- Children's Hospital, London Health Sciences Centre, London, Ontario, Canada
- Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
- The Hospital for Sick Children, Toronto, Ontario, Canada
- Montréal Children's Hospital, Montreal, Quebec, Canada
- University of Saskatchewan, Saskatoon, Saskatchewan, Canada
- Amalia Children's Hospital, Radboudumc, Nijmegen, Gelderland, Netherlands
- Sint Maartenskinderkliniek, Boxmeer, North Brabant, Netherlands
- Emma Children's Hospital, Amsterdam UMC, Amsterdam, North Holland, Netherlands
- +4 more locations on ClinicalTrials.gov
Collaborators
Canadian Institutes of Health Research (CIHR) · Genome Canada · Genome Alberta · The Arthritis Society, Canada · ReumaNederland · ZonMw: The Netherlands Organisation for Health Research and Development · Alberta Children's Hospital · Ontario Genomics
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06560606 on ClinicalTrials.govOther trials for Juvenile idiopathic arthritis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE3NCT07386587Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic ArthritisUniversity of Child Health Sciences and Children's Hospital, Lahore
- RECRUITINGPHASE3NCT06654882Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisDuke University
- RECRUITINGNCT07243782Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in KoreaNovartis Pharmaceuticals
- RECRUITINGNANCT07217782Pain in Juvenile ArthritisWashington University School of Medicine
- RECRUITINGNCT07185750Investigation of Catastrophizing of Pain Reported by Parents in JIA PatientsHacettepe University
- RECRUITINGNCT06806774Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic ArthritisHacettepe University
- RECRUITINGNANCT07234747Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic ArthritisIstanbul University - Cerrahpasa
- RECRUITINGNANCT06474546Feasibility of a Diet Intervention for Juvenile ArthritisThe Hospital for Sick Children